Search results
Results from the WOW.Com Content Network
Microcrystalline cellulose (MCC) is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production. [1] The most common form is used in vitamin supplements or tablets.
The global microcrystalline cellulose market is witnessing significant growth, driven by its versatile applications across various industries such as pharmaceuticals, food and beverages, and personal care. As consumer preferences shift towards natural and sustainable products, MCC has emerged as a preferred choice due to its biodegradability ...
[14] [15] This material was later referred to as microcrystalline cellulose (MCC) and commercialised under the name Avicel by FMC Corporation. [16] Nanocellulose gel (probably MFC of NFC) Microfibrillated cellulose (MFC) was discovered later, in the 1980s, by Turbak, Snyder and Sandberg at the ITT Rayonier labs in Shelton, Washington.
Cellulose is the raw material in the manufacture of nitrocellulose (cellulose nitrate) which is used in smokeless gunpowder. Pharmaceuticals: Cellulose derivatives, such as microcrystalline cellulose (MCC), have the advantages of retaining water, being a stabilizer and thickening agent, and in reinforcement of drug tablets. [73]
A wide variety of binders may be used: some common ones are lactose, dibasic calcium phosphate, sucrose, corn (maize) starch, microcrystalline cellulose, povidone polyvinylpyrrolidone and modified cellulose (for example, hydroxypropyl methylcellulose and hydroxyethylcellulose).
Malvern Panalytical is a Spectris plc company. [6] The company is a manufacturer and supplier of laboratory analytical instruments. [7] [8] It has been influential in the development of the Malvern Correlator, [9] and it remains notable for its work in the advancement of particle sizing technology. [10]
The New Jersey-based company faced inflationary pressures on product costs, which reduced consumer spending, according to CEO Barry Litwin, as well as $800 million in outstanding debt. Red Lobster
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.